Accbt corp - direct investment history in Brainstorm cell therapeutics inc

Filed on 2011-04-28 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0001144204-11-024696.txt Sec File: edgar/data/1406303/0001144204-11-024696-index.htm

2011-01-23 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc sold 10499999 shares at $0 remaining shares owned 0

Right To Acquire Common Stock Brainstorm Cell Therapeutics Inc Bcli exercise date 2007-07-02 exercise price 0.12 has valueunderlying security shares 10499999 underlying security title Common Stock

f3 there was no expiration date with respect to the reporting person's right to acquire the shares of common stock and warrantsto purchase common stock pursuant to the subscription agreement as amended. as of january 23, 2011, the reporting personinvested the full subscription price and has acquired all the shares of common stock and warrants to purchase common stockpursuant to the subscription agreement as amended.


Filed on 2011-04-28 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0001144204-11-024696.txt Sec File: edgar/data/1406303/0001144204-11-024696-index.htm

2011-01-23 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc sold 4537500 shares at $0 remaining shares owned 0

Right To Acquire Warrant To Purchase Common Stock Brainstorm Cell Therapeutics Inc Bcli exercise date 2007-07-02 exercise price 0 has valueunderlying security shares 4537500 underlying security title Common Stock

f3 there was no expiration date with respect to the reporting person's right to acquire the shares of common stock and warrantsto purchase common stock pursuant to the subscription agreement as amended. as of january 23, 2011, the reporting personinvested the full subscription price and has acquired all the shares of common stock and warrants to purchase common stockpursuant to the subscription agreement as amended.


Filed on 2011-04-28 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0001144204-11-024696.txt Sec File: edgar/data/1406303/0001144204-11-024696-index.htm

2011-01-23 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc bought 4537500 shares at $0 remaining shares owned 4537500

Warrant To Purchase Common Stock Brainstorm Cell Therapeutics Inc Bcli exercise date 2011-01-23 exercise price 0.29 has valueitem expiration due date 2013-11-05 underlying security shares 4537500 underlying security title Common Stock


Filed on 2011-04-28 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0001144204-11-024696.txt Sec File: edgar/data/1406303/0001144204-11-024696-index.htm

2010-02-24 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc sold 2000001 shares at $0 remaining shares owned 10499999

Right To Acquire Common Stock Brainstorm Cell Therapeutics Inc Bcli exercise date 2007-07-02 exercise price 0.12 has valueunderlying security shares 12500000 underlying security title Common Stock

f10 the reporting person acquired the right to purchase these shares of common stock pursuant to the subscription agreement, asamended, by and between the reporting person and brainstorm. the reporting person designated certain other parties topurchase from brainstorm these 2,000,001 shares it was then entitled to purchase under the subscription agreement, asamended.
f3 there was no expiration date with respect to the reporting person's right to acquire the shares of common stock and warrantsto purchase common stock pursuant to the subscription agreement as amended. as of january 23, 2011, the reporting personinvested the full subscription price and has acquired all the shares of common stock and warrants to purchase common stockpursuant to the subscription agreement as amended.


Filed on 2011-04-28 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0001144204-11-024696.txt Sec File: edgar/data/1406303/0001144204-11-024696-index.htm

2009-10-05 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc sold 4537500 shares at $0 remaining shares owned 4537500

Right To Acquire Warrant To Purchase Common Stock Brainstorm Cell Therapeutics Inc Bcli exercise date 2007-07-02 exercise price 0 has valueunderlying security shares 9075000 underlying security title Common Stock

f3 there was no expiration date with respect to the reporting person's right to acquire the shares of common stock and warrantsto purchase common stock pursuant to the subscription agreement as amended. as of january 23, 2011, the reporting personinvested the full subscription price and has acquired all the shares of common stock and warrants to purchase common stockpursuant to the subscription agreement as amended.


Filed on 2011-04-28 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0001144204-11-024696.txt Sec File: edgar/data/1406303/0001144204-11-024696-index.htm

2009-10-05 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc bought 4537500 shares at $0 remaining shares owned 4537500

Warrant To Purchase Common Stock Brainstorm Cell Therapeutics Inc Bcli exercise date 2009-10-05 exercise price 0.29 has valueitem expiration due date 2013-11-05 underlying security shares 4537500 underlying security title Common Stock


Filed on 2011-04-28 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0001144204-11-024696.txt Sec File: edgar/data/1406303/0001144204-11-024696-index.htm

2009-10-28 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc sold 9916667 shares at $0 remaining shares owned 12500000

Right To Acquire Common Stock Brainstorm Cell Therapeutics Inc Bcli exercise date 2007-07-02 exercise price 0.12 has valueunderlying security shares 22416667 underlying security title Common Stock

f9 the reporting person acquired the right to these shares of common stock pursuant to the amendment to the subscriptionagreement and the repricing thereunder. the reporting person designated certain other parties to receive from brainstormthese 9,916,667 shares it was then entitled to receive in connection with the retroactive application of the repricing toall shares purchased by the reporting person prior to the amendment.
f3 there was no expiration date with respect to the reporting person's right to acquire the shares of common stock and warrantsto purchase common stock pursuant to the subscription agreement as amended. as of january 23, 2011, the reporting personinvested the full subscription price and has acquired all the shares of common stock and warrants to purchase common stockpursuant to the subscription agreement as amended.


Filed on 2011-04-28 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0001144204-11-024696.txt Sec File: edgar/data/1406303/0001144204-11-024696-index.htm

2009-08-18 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc bought 14166667 shares at $0 remaining shares owned 22416667

Right To Acquire Common Stock Brainstorm Cell Therapeutics Inc Bcli exercise date 2009-08-18 exercise price 0.12 has valueunderlying security shares 8250000 underlying security title Common Stock

f8 the shares of common stock may be acquired by the reporting person pursuant to the terms of the amendment to the subscriptionagreement, entered into on august 18, 2009, by and between the reporting person and brainstorm. the amendment to thesubscription agreement provided that, among other things, the purchase price of the up to 27,500,000 shares of common stockthat the reporting person previously purchased or will purchase pursuant to the terms of the subscription agreement woulddecrease from $0.1818 to $0.12 (the "repricing"). therefore, the number of shares of common stock issuable to the reportingperson under the subscription agreement was adjusted in accordance with the repricing. the repricing retroactively appliedto all shares purchased by the reporting person prior to the amendment.
f3 there was no expiration date with respect to the reporting person's right to acquire the shares of common stock and warrantsto purchase common stock pursuant to the subscription agreement as amended. as of january 23, 2011, the reporting personinvested the full subscription price and has acquired all the shares of common stock and warrants to purchase common stockpursuant to the subscription agreement as amended.


Filed on 2011-04-28 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0001144204-11-024696.txt Sec File: edgar/data/1406303/0001144204-11-024696-index.htm

2009-08-18 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc bought 1008334 shares remaining shares owned 1008334

Warrant To Purchase Common Stock Brainstorm Cell Therapeutics Inc Bcli exercise price 0.29 has valueitem expiration due date 2013-11-05 underlying security shares 1008334 underlying security title Common Stock

f7 the four reported transactions involved amendments of outstanding warrants, resulting in the deemed cancellation of thewarrants and the issuance of replacement warrants. the warrants were originally issued on september 8, 2008.


Filed on 2011-04-28 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0001144204-11-024696.txt Sec File: edgar/data/1406303/0001144204-11-024696-index.htm

2009-08-18 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc sold 1008334 shares remaining shares owned 0

Warrant To Purchase Common Stock Brainstorm Cell Therapeutics Inc Bcli exercise price 0.36 has valueitem expiration due date 2011-11-05 underlying security shares 1008334 underlying security title Common Stock

f7 the four reported transactions involved amendments of outstanding warrants, resulting in the deemed cancellation of thewarrants and the issuance of replacement warrants. the warrants were originally issued on september 8, 2008.


Filed on 2011-04-28 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0001144204-11-024696.txt Sec File: edgar/data/1406303/0001144204-11-024696-index.htm

2009-08-18 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc bought 3529166 shares remaining shares owned 3529166

Warrant To Purchase Common Stock Brainstorm Cell Therapeutics Inc Bcli exercise price 0.29 has valueitem expiration due date 2013-11-05 underlying security shares 3529166 underlying security title Common Stock

f7 the four reported transactions involved amendments of outstanding warrants, resulting in the deemed cancellation of thewarrants and the issuance of replacement warrants. the warrants were originally issued on september 8, 2008.


Filed on 2011-04-28 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0001144204-11-024696.txt Sec File: edgar/data/1406303/0001144204-11-024696-index.htm

2009-08-18 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc sold 3529166 shares remaining shares owned 0

Warrant To Purchase Common Stock Brainstorm Cell Therapeutics Inc Bcli exercise price 0.29 has valueitem expiration due date 2011-11-05 underlying security shares 3529166 underlying security title Common Stock

f7 the four reported transactions involved amendments of outstanding warrants, resulting in the deemed cancellation of thewarrants and the issuance of replacement warrants. the warrants were originally issued on september 8, 2008.


Filed on 2011-04-28 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0001144204-11-024696.txt Sec File: edgar/data/1406303/0001144204-11-024696-index.htm

2009-08-18 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc bought 4537500 shares remaining shares owned 4537500

Warrant To Purchase Common Stock Brainstorm Cell Therapeutics Inc Bcli exercise price 0.29 has valueitem expiration due date 2013-11-05 underlying security shares 4537500 underlying security title Common Stock

f6 the two reported transactions involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the"old" warrant and the issuance of a replacement warrant. the warrant was originally issued on april 3, 2008.


Filed on 2011-04-28 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0001144204-11-024696.txt Sec File: edgar/data/1406303/0001144204-11-024696-index.htm

2009-08-18 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc sold 4537500 shares remaining shares owned 0

Warrant To Purchase Common Stock Brainstorm Cell Therapeutics Inc Bcli exercise price 0.29 has valueitem expiration due date 2011-11-05 underlying security shares 4537500 underlying security title Common Stock

f6 the two reported transactions involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the"old" warrant and the issuance of a replacement warrant. the warrant was originally issued on april 3, 2008.


Filed on 2011-04-28 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0001144204-11-024696.txt Sec File: edgar/data/1406303/0001144204-11-024696-index.htm

2009-08-18 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc bought 2016667 shares remaining shares owned 2016667

Warrant To Purchase Common Stock Brainstorm Cell Therapeutics Inc Bcli exercise price 0.29 has valueitem expiration due date 2013-11-05 underlying security shares 2016667 underlying security title Common Stock

f5 the four reported transactions involved amendments of outstanding warrants, resulting in the deemed cancellation of thewarrants and the issuance of replacement warrants. the warrants were originally issued on november 12, 2007.


Filed on 2011-04-28 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0001144204-11-024696.txt Sec File: edgar/data/1406303/0001144204-11-024696-index.htm

2009-08-18 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc sold 2016667 shares remaining shares owned 0

Warrant To Purchase Common Stock Brainstorm Cell Therapeutics Inc Bcli exercise price 0.29 has valueitem expiration due date 2011-11-05 underlying security shares 2016667 underlying security title Common Stock

f5 the four reported transactions involved amendments of outstanding warrants, resulting in the deemed cancellation of thewarrants and the issuance of replacement warrants. the warrants were originally issued on november 12, 2007.


Filed on 2011-04-28 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0001144204-11-024696.txt Sec File: edgar/data/1406303/0001144204-11-024696-index.htm

2009-08-18 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc bought 2520833 shares remaining shares owned 2520833

Warrant To Purchase Common Stock Brainstorm Cell Therapeutics Inc Bcli exercise price 0.2 has valueitem expiration due date 2013-11-05 underlying security shares 2520833 underlying security title Common Stock

f5 the four reported transactions involved amendments of outstanding warrants, resulting in the deemed cancellation of thewarrants and the issuance of replacement warrants. the warrants were originally issued on november 12, 2007.


Filed on 2011-04-28 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0001144204-11-024696.txt Sec File: edgar/data/1406303/0001144204-11-024696-index.htm

2009-08-18 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc sold 2520833 shares remaining shares owned 0

Warrant To Purchase Common Stock Brainstorm Cell Therapeutics Inc Bcli exercise price 0.2 has valueitem expiration due date 2011-11-05 underlying security shares 2520833 underlying security title Common Stock

f5 the four reported transactions involved amendments of outstanding warrants, resulting in the deemed cancellation of thewarrants and the issuance of replacement warrants. the warrants were originally issued on november 12, 2007.


Filed on 2011-04-28 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0001144204-11-024696.txt Sec File: edgar/data/1406303/0001144204-11-024696-index.htm

2009-08-18 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc bought 7562500 shares remaining shares owned 7562500

Warrant To Purchase Common Stock Brainstorm Cell Therapeutics Inc Bcli exercise price 0.2 has valueitem expiration due date 2013-11-05 underlying security shares 7562500 underlying security title Common Stock

f4 the two reported transactions involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the"old" warrant and the issuance of a replacement warrant. the warrant was originally issued on august 10, 2007.


Filed on 2011-04-28 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0001144204-11-024696.txt Sec File: edgar/data/1406303/0001144204-11-024696-index.htm

2009-08-18 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc sold 7562500 shares remaining shares owned 0

Warrant To Purchase Common Stock Brainstorm Cell Therapeutics Inc Bcli exercise price 0.2 has valueitem expiration due date 2011-11-05 underlying security shares 7562500 underlying security title Common Stock

f4 the two reported transactions involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the"old" warrant and the issuance of a replacement warrant. the warrant was originally issued on august 10, 2007.


Filed on 2011-04-28 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0001144204-11-024696.txt Sec File: edgar/data/1406303/0001144204-11-024696-index.htm

2008-09-08 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc sold 4537500 shares at $0 remaining shares owned 9075000

Right To Acquire Warrant To Purchase Common Stock Brainstorm Cell Therapeutics Inc Bcli exercise date 2007-07-02 exercise price 0 has valueunderlying security shares 13612500 underlying security title Common Stock

f3 there was no expiration date with respect to the reporting person's right to acquire the shares of common stock and warrantsto purchase common stock pursuant to the subscription agreement as amended. as of january 23, 2011, the reporting personinvested the full subscription price and has acquired all the shares of common stock and warrants to purchase common stockpursuant to the subscription agreement as amended.


Filed on 2011-04-28 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0001144204-11-024696.txt Sec File: edgar/data/1406303/0001144204-11-024696-index.htm

2008-09-08 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc sold 4125000 shares at $0 remaining shares owned 8250000

Right To Acquire Common Stock Brainstorm Cell Therapeutics Inc Bcli exercise date 2007-07-02 exercise price 0.1818 has valueunderlying security shares 12375000 underlying security title Common Stock

f3 there was no expiration date with respect to the reporting person's right to acquire the shares of common stock and warrantsto purchase common stock pursuant to the subscription agreement as amended. as of january 23, 2011, the reporting personinvested the full subscription price and has acquired all the shares of common stock and warrants to purchase common stockpursuant to the subscription agreement as amended.


Filed on 2011-04-28 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0001144204-11-024696.txt Sec File: edgar/data/1406303/0001144204-11-024696-index.htm

2008-09-08 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc bought 1008334 shares at $0 remaining shares owned 1008334

Warrant To Purchase Common Stock Brainstorm Cell Therapeutics Inc Bcli exercise date 2008-09-08 exercise price 0.36 has valueitem expiration due date 2011-11-05 underlying security shares 1008334 underlying security title Common Stock


Filed on 2011-04-28 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0001144204-11-024696.txt Sec File: edgar/data/1406303/0001144204-11-024696-index.htm

2008-09-08 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc bought 3529166 shares at $0 remaining shares owned 3529166

Warrant To Purchase Common Stock Brainstorm Cell Therapeutics Inc Bcli exercise date 2008-09-08 exercise price 0.29 has valueitem expiration due date 2011-11-05 underlying security shares 3529166 underlying security title Common Stock


Filed on 2011-04-28 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0001144204-11-024696.txt Sec File: edgar/data/1406303/0001144204-11-024696-index.htm

2011-01-23 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc bought 10499999 shares at $0.12 remaining shares owned 29006924

Common Stock Brainstorm Cell Therapeutics Inc Bcli Transaction code: M Exercise or conversion of derivative security

f2 the reporting person acquired the shares of common stock pursuant to that certain subscription agreement, dated as of july 2,2007, and as amended on august 18, 2009, between the reporting person and brainstorm. the aggregate purchase price for theshares of common stock was $1,260,000.


Filed on 2011-04-28 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0001144204-11-024696.txt Sec File: edgar/data/1406303/0001144204-11-024696-index.htm

2008-09-08 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc bought 4125000 shares at $0.1818 remaining shares owned 18506925

Common Stock Brainstorm Cell Therapeutics Inc Bcli Transaction code: M Exercise or conversion of derivative security

f1 the reporting person acquired the shares of common stock pursuant to that certain subscription agreement, dated as of july 2,2007, between the reporting person and brainstorm cell therapeutics inc. ("brainstorm"). the aggregate purchase price forthe shares of common stock was $750,000.


Filed on 2008-04-28 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0001181431-08-026844.txt Sec File: edgar/data/1406303/0001181431-08-026844-index.htm

2008-04-03 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc sold 4537500 shares at $0 remaining shares owned 13612500

Right To Acquire Warrant To Purchase Common Stock Brainstorm Cell Therapeutics Inc Bcli exercise date 2007-07-02 exercise price 0 has valueunderlying security shares 18150000 underlying security title Common Stock

f2 there is no expiration date with respect to the reporting person's right to acquire shares of common stock and warrants to purchase common stock pursuant to the subscription agreement.


Filed on 2008-04-28 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0001181431-08-026844.txt Sec File: edgar/data/1406303/0001181431-08-026844-index.htm

2008-04-03 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc sold 4125000 shares at $0 remaining shares owned 12375000

Right To Acquire Common Stock Brainstorm Cell Therapeutics Inc Bcli exercise date 2007-07-02 exercise price 0.1818 has valueunderlying security shares 16500000 underlying security title Common Stock

f1 the reporting person acquired the right to purchase shares of common stock pursuant to that certain subscription agreement (the "subscription agreement"), dated as of july 2, 2007, between the reporting person and brainstorm cell therapeutics inc. ("brainstorm"). on april 3, 2008, the reporting person elected to purchase from brainstorm 2,000,000 shares of common stock and the reporting person designated certain other parties to purchase from brainstorm the remaining 2,125,000 shares of common stock it was then entitled to purchase under the subscription agreement. the aggregate purchase price for the shares of common stock was $750,000.
f2 there is no expiration date with respect to the reporting person's right to acquire shares of common stock and warrants to purchase common stock pursuant to the subscription agreement.


Filed on 2008-04-28 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0001181431-08-026844.txt Sec File: edgar/data/1406303/0001181431-08-026844-index.htm

2008-04-03 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc bought 4537500 shares at $0 remaining shares owned 4537500

Warrant To Purchase Common Stock Brainstorm Cell Therapeutics Inc Bcli exercise date 2008-04-03 exercise price 0.29 has valueitem expiration due date 2011-11-05 underlying security shares 4537500 underlying security title Common Stock


Filed on 2008-04-28 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0001181431-08-026844.txt Sec File: edgar/data/1406303/0001181431-08-026844-index.htm

2008-04-03 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc bought 2000000 shares at $0.1818 remaining shares owned 14381925

Common Stock Brainstorm Cell Therapeutics Inc Bcli Transaction code: M Exercise or conversion of derivative security

f1 the reporting person acquired the right to purchase shares of common stock pursuant to that certain subscription agreement (the "subscription agreement"), dated as of july 2, 2007, between the reporting person and brainstorm cell therapeutics inc. ("brainstorm"). on april 3, 2008, the reporting person elected to purchase from brainstorm 2,000,000 shares of common stock and the reporting person designated certain other parties to purchase from brainstorm the remaining 2,125,000 shares of common stock it was then entitled to purchase under the subscription agreement. the aggregate purchase price for the shares of common stock was $750,000.


Filed on 2007-11-16 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0001181431-07-069850.txt Sec File: edgar/data/1406303/0001181431-07-069850-index.htm

2007-11-12 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc sold 4537500 shares at $0 remaining shares owned 18150000

Right To Acquire Warrant To Purchase Common Stock Brainstorm Cell Therapeutics Inc Bcli exercise date 2007-07-02 exercise price 0 has valueunderlying security shares 22687500 underlying security title Common Stock

f2 there is no expiration date with respect to the reporting person's right to acquire the shares of common stock and warrants to purchase common stock pursuant to the subscription agreement.


Filed on 2007-11-16 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0001181431-07-069850.txt Sec File: edgar/data/1406303/0001181431-07-069850-index.htm

2007-11-12 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc sold 4125000 shares at $0 remaining shares owned 16500000

Right To Acquire Common Stock Brainstorm Cell Therapeutics Inc Bcli exercise date 2007-07-02 exercise price 0.1818 has valueunderlying security shares 20625000 underlying security title Common Stock

f2 there is no expiration date with respect to the reporting person's right to acquire the shares of common stock and warrants to purchase common stock pursuant to the subscription agreement.


Filed on 2007-11-16 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0001181431-07-069850.txt Sec File: edgar/data/1406303/0001181431-07-069850-index.htm

2007-11-12 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc bought 2016667 shares at $0 remaining shares owned 2016667

Warrant To Purchase Common Stock Brainstorm Cell Therapeutics Inc Bcli exercise date 2007-11-12 exercise price 0.29 has valueitem expiration due date 2011-11-05 underlying security shares 2016667 underlying security title Common Stock


Filed on 2007-11-16 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0001181431-07-069850.txt Sec File: edgar/data/1406303/0001181431-07-069850-index.htm

2007-11-12 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc bought 2520833 shares at $0 remaining shares owned 2520833

Warrant To Purchase Common Stock Brainstorm Cell Therapeutics Inc Bcli exercise date 2007-11-12 exercise price 0.2 has valueitem expiration due date 2011-11-05 underlying security shares 2520833 underlying security title Common Stock


Filed on 2007-11-16 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0001181431-07-069850.txt Sec File: edgar/data/1406303/0001181431-07-069850-index.htm

2007-11-12 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc bought 4125000 shares at $0.1818 remaining shares owned 12381925

Common Stock Brainstorm Cell Therapeutics Inc Bcli Transaction code: M Exercise or conversion of derivative security

f1 the reporting person acquired the shares of common stock pursuant to that certain subscription agreement (the "subscription agreement"), dated as of july 2, 2007, between the reporting person and brainstorm cell therapeutics inc. ("brainstorm"). the aggregate purchase price for the shares of common stock was $750,000.


Filed on 2007-09-10 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0001181431-07-056698.txt Sec File: edgar/data/1406303/0001181431-07-056698-index.htm

2007-09-06 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc sold 3181925 shares at $636385 remaining shares owned 0

Right To Acquire Warrant To Purchase Common Stock Brainstorm Cell Therapeutics Inc Bcli exercise date 2007-08-02 exercise price 0 has valueunderlying security shares 3181925 underlying security title Common Stock

f1 accbt corp. ("accbt") acquired the warrant to purchase shares of common stock of brainstorm cell therapeutics inc. ("brainstorm") pursuant to a warrant purchase agreement (the "agreement") between accbt and ramot at tel aviv university ltd. ("ramot") dated august 2, 2007. the agreement provided accbt with the right to acquire from ramot a warrant to purchase an aggregate of 3,181,925 shares of common stock of brainstorm for an aggregate purchase price of $636,385. on september 6, 2007, accbt elected to purchase from ramot under the agreement a warrant to purchase an aggregate of 1,181,925 shares of common stock for an aggregate purchase price of $236,385. also on september 6, 2007, accbt designated certain other parties to purchase from ramot the remaining warrants under the agreement to purchase 2,000,000 shares of brainstorm common stock. therefore, accbt's right to acquire additional warrants from ramot under the agreement terminatedas of september 6, 2007.


Filed on 2007-09-10 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0001181431-07-056698.txt Sec File: edgar/data/1406303/0001181431-07-056698-index.htm

2007-09-06 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc bought 1181925 shares at $236385 remaining shares owned 1181925

Warrant To Purchase Common Stock Brainstorm Cell Therapeutics Inc Bcli exercise date 2007-09-06 exercise price 0.01 has valueitem expiration due date 2010-11-04 underlying security shares 1181925 underlying security title Common Stock

f1 accbt corp. ("accbt") acquired the warrant to purchase shares of common stock of brainstorm cell therapeutics inc. ("brainstorm") pursuant to a warrant purchase agreement (the "agreement") between accbt and ramot at tel aviv university ltd. ("ramot") dated august 2, 2007. the agreement provided accbt with the right to acquire from ramot a warrant to purchase an aggregate of 3,181,925 shares of common stock of brainstorm for an aggregate purchase price of $636,385. on september 6, 2007, accbt elected to purchase from ramot under the agreement a warrant to purchase an aggregate of 1,181,925 shares of common stock for an aggregate purchase price of $236,385. also on september 6, 2007, accbt designated certain other parties to purchase from ramot the remaining warrants under the agreement to purchase 2,000,000 shares of brainstorm common stock. therefore, accbt's right to acquire additional warrants from ramot under the agreement terminatedas of september 6, 2007.


Filed on 2007-09-10 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0001181431-07-056698.txt Sec File: edgar/data/1406303/0001181431-07-056698-index.htm

2007-09-10 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc sold 1181925 shares at $0 remaining shares owned 0

Warrant To Purchase Common Stock Brainstorm Cell Therapeutics Inc Bcli exercise date 2007-09-06 exercise price 0.01 has valueitem expiration due date 2010-11-04 underlying security shares 1181925 underlying security title Common Stock


Filed on 2007-09-10 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0001181431-07-056698.txt Sec File: edgar/data/1406303/0001181431-07-056698-index.htm

2007-09-10 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc bought 1181925 shares at $11819 remaining shares owned 8256925

Common Stock Brainstorm Cell Therapeutics Inc Bcli Transaction code: M Exercise or conversion of derivative security


Filed on 2007-08-17 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0000898430-07-003185.txt Sec File: edgar/data/1406303/0000898430-07-003185-index.htm

2007-08-10 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc sold 7562500 shares at $0 remaining shares owned 22687500

Right To Acquire Warrant To Purchase Common Stock Brainstorm Cell Therapeutics Inc Bcli exercise date 2007-07-02 exercise price 0 has valueunderlying security shares 30250000 underlying security title Common Stock

f2 there is no expiration date with respect to the reporting person's right to acquire the shares of common stock and warrants to purchase common stock pursuant to the subcription agreement.


Filed on 2007-08-17 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0000898430-07-003185.txt Sec File: edgar/data/1406303/0000898430-07-003185-index.htm

2007-08-10 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc sold 6875000 shares at $0 remaining shares owned 20625000

Right To Acquire Common Stock Brainstorm Cell Therapeutics Inc Bcli exercise date 2007-07-02 exercise price 0.1818 has valueunderlying security shares 27500000 underlying security title Common Stock

f2 there is no expiration date with respect to the reporting person's right to acquire the shares of common stock and warrants to purchase common stock pursuant to the subcription agreement.


Filed on 2007-08-17 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0000898430-07-003185.txt Sec File: edgar/data/1406303/0000898430-07-003185-index.htm

2007-08-10 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc bought 7562500 shares at $0 remaining shares owned 7562500

Warrant To Purchase Common Stock Brainstorm Cell Therapeutics Inc Bcli exercise date 2007-08-10 exercise price 0.2 has valueitem expiration due date 2011-11-05 underlying security shares 7562500 underlying security title Common Stock


Filed on 2007-08-17 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0000898430-07-003185.txt Sec File: edgar/data/1406303/0000898430-07-003185-index.htm

2007-08-10 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc bought 6875000 shares at $0.1818 remaining shares owned 7075000

Common Stock Brainstorm Cell Therapeutics Inc Bcli Transaction code: M Exercise or conversion of derivative security

f1 the reporting person acquired the shares of common stock pursuant to that certain subscription agreement (the "subscription agreement"), dated as of july 2, 2007, between the reporting person and brainstorm cell therapeutics inc. ("brainstorm"). the aggregate purchase price for the shares of common stock was $1,250,000, of which $1,000,000 was paid in cash by the reporting person to brainstorm and $250,000 was paid by the application of the outstanding principal amount owed by brainstorm to the reporting person pursuant to that certain 8% convertible promissory note, dated may 6, 2007, in the principal amount of $250,000 issued by brainstorm to the reporting person.


Filed on 2007-08-17 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0000898430-07-003185.txt Sec File: edgar/data/1406303/0000898430-07-003185-index.htm

2007-08-15 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc bought 4500 shares at $1.07 remaining shares owned 7075000

Common Stock Brainstorm Cell Therapeutics Inc Bcli Transaction code: P Open market or private purchase of securities


Filed on 2007-08-17 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0000898430-07-003185.txt Sec File: edgar/data/1406303/0000898430-07-003185-index.htm

2007-08-15 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc bought 20500 shares at $1.0597 remaining shares owned 7075000

Common Stock Brainstorm Cell Therapeutics Inc Bcli Transaction code: P Open market or private purchase of securities


Filed on 2007-08-17 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0000898430-07-003185.txt Sec File: edgar/data/1406303/0000898430-07-003185-index.htm

2007-08-14 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc bought 20500 shares at $1.0797 remaining shares owned 7075000

Common Stock Brainstorm Cell Therapeutics Inc Bcli Transaction code: P Open market or private purchase of securities


Filed on 2007-08-17 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0000898430-07-003185.txt Sec File: edgar/data/1406303/0000898430-07-003185-index.htm

2007-08-13 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc bought 29500 shares at $1.0491 remaining shares owned 7075000

Common Stock Brainstorm Cell Therapeutics Inc Bcli Transaction code: P Open market or private purchase of securities


Filed on 2007-08-17 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0000898430-07-003185.txt Sec File: edgar/data/1406303/0000898430-07-003185-index.htm

2007-08-13 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc bought 16000 shares at $1.05 remaining shares owned 7075000

Common Stock Brainstorm Cell Therapeutics Inc Bcli Transaction code: P Open market or private purchase of securities


Filed on 2007-08-17 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0000898430-07-003185.txt Sec File: edgar/data/1406303/0000898430-07-003185-index.htm

2007-08-10 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc bought 20500 shares at $0.9663 remaining shares owned 7075000

Common Stock Brainstorm Cell Therapeutics Inc Bcli Transaction code: P Open market or private purchase of securities


Filed on 2007-08-17 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0000898430-07-003185.txt Sec File: edgar/data/1406303/0000898430-07-003185-index.htm

2007-08-10 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc bought 13500 shares at $1 remaining shares owned 7075000

Common Stock Brainstorm Cell Therapeutics Inc Bcli Transaction code: P Open market or private purchase of securities


Filed on 2007-08-17 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0000898430-07-003185.txt Sec File: edgar/data/1406303/0000898430-07-003185-index.htm

2007-08-09 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc bought 66500 shares at $1.01 remaining shares owned 7075000

Common Stock Brainstorm Cell Therapeutics Inc Bcli Transaction code: P Open market or private purchase of securities


Filed on 2007-08-17 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0000898430-07-003185.txt Sec File: edgar/data/1406303/0000898430-07-003185-index.htm

2007-08-09 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc bought 8500 shares at $1.0247 remaining shares owned 7075000

Common Stock Brainstorm Cell Therapeutics Inc Bcli Transaction code: P Open market or private purchase of securities


Filed on 2007-08-08 by Accbt Corp. SEC CIK 1406303 Form 4

Accession 0001181431-07-050750.txt Sec File: edgar/data/1406303/0001181431-07-050750-index.htm

2007-08-02 Accbt Corp (CIK 1406303) through Direct

Invested in Brainstorm Cell Therapeutics Inc bought 3181925 shares remaining shares owned 3181925

Right To Acquire Warrant To Purchase Common Stock Brainstorm Cell Therapeutics Inc Bcli exercise date 2007-08-02 exercise price 636385 has valueunderlying security shares 3181925 underlying security title Warrant To Purchase Common Stock

f1 pursuant to a warrant purchase agreement entered into between accbt corp. ("accbt") and ramot at tel aviv university ltd. ("ramot") on august 2, 2007, accbt has the right to acquire a warrant from ramot to purchase an aggregate of 3,181,925 shares of common stock of brainstorm cell therapeutics inc. the aggregate purchase price for the warrant is $636,385. the shares of common stock subject to the warrant may be purchased for a purchase price of $0.01 per share. the warrant will expire on november 4, 2010. the closing of the sale of the warrant from ramot to accbt is scheduled to occur on august 31, 2007. however, because accbt has the right to acquire the warrant at any time prior to august 31, 2007, accbt may be deemed the beneficial owner of the warrant.